SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-16-019484
Filing Date
2016-12-16
Accepted
2016-12-16 17:02:14
Documents
6
Period of Report
2016-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k121316_soligenixinc.htm 8-K 32122
2 WARRANT AGENCY AGREEMENT DATED DECEMBER 16, 2016 BETWEEN SOLIGENIX, INC. AND AME f8k121316ex10i_soligenix.htm EX-10.1 121693
3 PRESS RELEASE ISSUED BY SOLIGENIX, INC. ON DECEMBER 13, 2016 f8k121316ex99i_soligenix.htm EX-99.1 12024
4 PRESS RELEASE ISSUED BY SOLIGENIX, INC. ON DECEMBER 16, 2016. f8k121316ex99ii_soligenix.htm EX-99.2 10991
5 GRAPHIC image_001.jpg GRAPHIC 52368
6 GRAPHIC image_002.jpg GRAPHIC 11849
  Complete submission text file 0001213900-16-019484.txt   266779
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 162057000
SIC: 2834 Pharmaceutical Preparations